Status:

UNKNOWN

Lung Microbiota Analysis in Critically Ill Patients Admitted to the Intensive Care Unit.

Lead Sponsor:

Fondazione Policlinico Universitario Agostino Gemelli IRCCS

Conditions:

Lung Microbiota

Eligibility:

All Genders

18+ years

Brief Summary

Our study aims to evaluate the relationship between the heterogeneity of pulmonary microbiota and clinical and outcome variables among critically ill patients admitted to the intensive care unit (ICU)...

Detailed Description

Traditionally, microbiological investigations and clinical trials have contributed to the definition of lower airways as a physiologically sterile district, whose microbiological balance is altered wh...

Eligibility Criteria

Inclusion

  • execution of bronchoalveolar lavage sampling, either for clinical indications or in the context of surveillance programs
  • acquisition of an informed consent

Exclusion

  • presence of significant coagulation abnormalities and/or severe respiratory failure
  • clearly bloody BAL sample
  • small quantity of BAL sample (\<5 ml)

Key Trial Info

Start Date :

November 15 2019

Trial Type :

OBSERVATIONAL

Allocation :

ESTIMATED

End Date :

April 30 2023

Estimated Enrollment :

150 Patients enrolled

Trial Details

Trial ID

NCT04271345

Start Date

November 15 2019

End Date

April 30 2023

Last Update

March 25 2022

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Fondazione Policlinico A. Gemelli IRCCS

Rome, Italy, 00168

Lung Microbiota Analysis in Critically Ill Patients Admitted to the Intensive Care Unit. | DecenTrialz